"Product (Company, therapeutic area)",NPV in billion U.S. dollars
"Tirzepatide (Eli Lilly, diabetes)",11.72
"BMS-986165 (BMS, autoimmune)",6.74
TransCon Growth Hormone (Ascendis Pharma),5.36
"Bempegaldesleukin (Nektar Therapeutics, cancer)",4.8
"SAGE-217 (Sage Therapeutics, depression)",4.78
"Tezepelumab (Amgen, asthma)",4.7
"Mirikizumab (Eli Lilly, autoimmune)",4.66
"mRNA-2752 (cancer, Moderna)",4.62
"Efgartigimod (Argenx, autoimmune)",4.41
"RG7828 (Roche, blood cancer)",4.12
